Skip to main content
SpringerLink
Log in

Mechanisms of protection by pantoprazole against NSAID-induced gastric mucosal damage

  • Original Article
  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Abstract

The use of nonsteroidal anti-inflammatory drugs (NSAIDs) can be associated with severe adverse digestive effects. In clinical settings, proton pump inhibitors have proven to be effective in preventing and healing NSAID-induced gastroduodenal lesions. The present study investigates the mechanisms of protection afforded by pantoprazole against gastric injury induced by different NSAIDs in rats. Animals were orally treated with indomethacin (100 μmol/kg), diclofenac (60 μmol/kg), piroxicam (150 μmol/kg) or ketoprofen (150 μmol/kg). Thirty minutes before NSAIDs, animals received pantoprazole 6 or 60 μmol/kg orally. Four hours after NSAIDs, the following parameters were assessed: histomorphometric evaluation of gastric mucosal damage; gastric mucosal levels of myeloperoxidase (MPO), malondialdehyde (MDA), reduced glutathione as an index of non-proteic sulfhydryl compounds (GSH), and prostaglandin E2 (PGE2); mucosal cyclooxygenase-1 and -2 (COX-1, COX-2) mRNA expression by reverse transcription-polymerase chain reaction (RT-PCR). Separate experiments were carried out to assay the effects of pantoprazole on gastric acid secretion in pylorus-ligated rats. The in vitro influence of pantoprazole (1–10 μM) on the oxidation of low density lipoproteins (LDLs) induced by copper sulphate was also examined. All NSAIDs elicited mucosal necrotic lesions associated with neutrophil infiltration and reduction of PGE2 levels. Increments of MPO and MDA contents, as well as a decrease in GSH levels, were detected in the gastric mucosa of indomethacin-, piroxicam- or ketoprofen-treated animals. Indomethacin enhanced mucosal COX-2 expression, while not affecting COX-1. At the oral dose of 6 μmol/kg pantoprazole did not affect NSAID-induced mucosal damage, whereas at 60 μmol/kg it markedly reduced injuries provoked by all test NSAIDs. Pantoprazole 60 μmol/kg also reversed the effects of NSAIDs on MPO, MDA, and GSH mucosal contents, without interfering with the decrease in PGE2 levels or indomethacin-induced COX-2 expression. However, at both doses, pantoprazole inhibited acid secretion in pylorus-ligated rats. Furthermore, pantoprazole concentration dependently reduced the in vitro oxidation of LDLs. Our results suggest that besides inhibiting acid secretion, the protection afforded by pantoprazole against NSAID-induced gastric damage depends on a reduction in mucosal oxidative injury, which may also account for an increment of sulfhydryl radical mucosal bioavailability. It is also suggested that pantoprazole does not influence the down-regulation of gastric prostaglandin production associated with NSAID treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  • Agastya G, West BC, Callahan JM (2000) Omeprazole inhibits phagocytosis and acidification of phagolysosomes of normal human neutrophils in vitro. Immunopharmacol Immunotoxicol 22:357–372

    PubMed  Google Scholar 

  • Anthony A, Sim R, Dhillon AP, Pounder RE, Wakefield AJ (1996) Gastric mucosal contraction and vascular injury induced by indomethacin precede neutrophil infiltration in the rat. Gut 39:363–368

    PubMed  Google Scholar 

  • Avila JR, De la Lastra CA, Martin MJ, Motilva V, Luque I, Delgado I, Esteban J, Herrerias J (1996) Role of endogenous sulphydryls and neutrophil infiltration in the pathogenesis of gastric mucosal injury induced by piroxicam in rats. Inflamm Res 45:83–88

    PubMed  Google Scholar 

  • Bianchi Porro G, Lazzaroni M, Imbesi V, Montrone F, Santagada T (2000) Efficacy of pantoprazole in the prevention of peptic ulcers induced by non-steroidal anti-inflammatory drugs: a prospective, placebo-controlled, double-blind, parallel-group study. Dig Liver Dis 32:201–208

    Article  PubMed  Google Scholar 

  • Biswas K, Bandyopadhyay U, Chattopadhyay I, Varadaraj A, Ali E, Banerjee RK (2003) A novel antioxidant and antiapoptotic role of omeprazole to block gastric ulcer through scavenging of hydroxyl radical. J Biol Chem 278:10993–11001

    Article  PubMed  Google Scholar 

  • Blandizzi C, Gherardi G, Marveggio C, Natale G, Carignani D, Del Tacca M (1995) Mechanisms of protection by omeprazole against experimental gastric mucosal damage in rats. Digestion 56:220–229

    PubMed  Google Scholar 

  • Blandizzi C, Natale G, Gherardi G, Lazzeri G, Marveggio C, Colucci R, Carignani D, Del Tacca M (2000) Gastroprotective effects of pantoprazole against experimental mucosal damage. Fundam Clin Pharmacol 14:89–99

    PubMed  Google Scholar 

  • Carvajal A, Arias LH, Vega E, Sanchez JA, Rodriguez IM, Ortega PG, del Pozo JG (2004) Gastroprotection during the administration of non-steroidal anti-inflammatory drugs. A drug utilization study. Eur J Clin Pharmacol 60:439–444

    Article  PubMed  Google Scholar 

  • Cominacini L, Garbin U, Davoli A, Micciolo R, Bosello O, Gaviraghi G, Scuro LA, Pastorino AM (1991) A simple test for predisposition to LDL oxidation based on the fluorescence development during copper-catalyzed oxidative modification. J Lipid Res 32:349–358

    PubMed  Google Scholar 

  • Dajani EZ, Klamut MJ (2000) Novel therapeutic approaches to gastric and duodenal ulcers: an update. Expert Opin Investig Drugs 9:1537–1544

    Article  PubMed  Google Scholar 

  • De la Lastra CA, Nieto A, Martin MJ, Cabre F, Herrerias JM, Motilva V (2002) Gastric toxicity of racemic ketoprofen and its enatiomers in rat: oxygen radical generation and COX expression. Inflamm Res 51:51–57

    PubMed  Google Scholar 

  • Esterbauer H, Striegl G, Puhl H, Dieber Rothneder M (1989) Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun 6:67–75

    PubMed  Google Scholar 

  • Ferraz JG, Sharkey KA, Reuter BK, Asfaha S, Tigley AW, Brown ML, McKnight W, Wallace JL (1997) Induction of cyclooxygenase 1 and 2 in the rat stomach during endotoxemia: role in resistance to damage. Gastroenterology 113:195–204

    PubMed  Google Scholar 

  • Fiorucci S, Antonelli E, Morelli O, Morelli A (1999) Pathogenesis of non-steroidal antiinflammatory drug gastropathy. Ital J Gastroenterol Hepatol 31(Suppl 1):S6–S13

    PubMed  Google Scholar 

  • Fukuda T, Arakawa T, Shimizu Y, Ohtani K, Higuchi K, Kobayashi K (1995) Effects of lansoprazole on ethanol-induced injury and PG synthetic activity in rat gastric mucosa. J Clin Gastroenterol 20(Suppl 2):S5–S7

    PubMed  Google Scholar 

  • Hawkey CJ (2000) Nonsteroidal anti-inflammatory drug gastropathy. Gastroenterology 119:521–535

    Article  PubMed  Google Scholar 

  • Hayes JD, McLellan LI (1999) Glutathione and glutathione-dependent enzymes represent a coordinately regulated defence against oxidative stress. Free Radic Res 31:273–300

    PubMed  Google Scholar 

  • Hiraishi H, Shimada T, Terano A (2000) Involvement of oxidative stress in the pathogenesis of NSAID-induced gastric mucosal damage. J Gastroenterol 35:567–569

    Article  PubMed  Google Scholar 

  • Højgaard L, Mertz Nielsen A, Rune SJ (1996) Peptic ulcer pathophysiology: acid, bicarbonate, and mucosal function. Scand J Gastroenterol 31(Suppl 216):10–15

    PubMed  Google Scholar 

  • Janssen M, Dijkmans BAC, Vandenbroucke JP, Biemond I, Lamers CB (1994) Achlorhydria does not protect against benign upper gastrointestinal ulcers during NSAID use. Dig Dis Sci 39:362–365

    PubMed  Google Scholar 

  • Kwicien S, Brzozowski T, Konturek SJ (2002) Effects of reactive oxygen species action on gastric mucosa in various models of mucosal injury. J Physiol (Paris) 53:39–50

    Google Scholar 

  • Lapenna D, De Gioia S, Cofani G, Festi D, Cuccurullo F (1996) Antioxidant properties of omeprazole. FEBS Lett 382:189–192

    Article  PubMed  Google Scholar 

  • Lee M, Kallal SM, Feldman M (1996) Omeprazole prevents indomethacin-induced gastric ulcers in rabbits. Aliment Pharmacol Ther 10:571–576

    Article  PubMed  Google Scholar 

  • Lehmann F, Hildebrand P, Beglinger C (2003) New molecular targets for treatment of peptic ulcer disease. Drugs 63:1785–1797

    PubMed  Google Scholar 

  • Lichtenstein DR, Syngal S, Wolfe MM (1995) Nonsteroidal antiinflammatory drugs and the gastrointestinal tract: the double-edged sword. Arthritis Rheum 38:5–18

    PubMed  Google Scholar 

  • Loguercio C, Di Pierro M (1999) The role of glutathione in the gastrointestinal tract: a review. Ital J Gastroenterol Hepatol 31:401–407

    PubMed  Google Scholar 

  • Manjari V, Das UN (1998) Oxidant stress, anti-oxidants, nitric oxide and essential fatty acids in peptic ulcer disease. Prostaglandins Leukot Essent Fat Acids 59:401–406

    Article  Google Scholar 

  • Natale G, Lazzeri G, Blandizzi G, Gherardi G, Lenzi P, Pellegrini A, Del Tacca M (2001) Seriate histomorphometry of whole rat stomach: an accurate and reliable method for quantitative analysis of mucosal damage. Toxicol Appl Pharmacol 174:17–26

    Article  PubMed  Google Scholar 

  • Natale G, Lazzeri G, Lubrano V, Colucci R, Vassalle C, Fornai M, Blandizzi C, Del Tacca M (2004) Mechanisms of gastroprotection by lansoprazole pretreatment against experimentally induced injury in rats: role of mucosal oxidative damage and sulfhydryl compounds. Toxicol Appl Pharmacol 195:62–72

    Article  PubMed  Google Scholar 

  • Ota S, Takahashi M, Yoshiura K, Hata Y, Kawabe T, Terano A, Omata M (1993) Antiulcer drugs and gastric prostaglandin E2: an in vitro study. J Clin Gastroenterol 17(Suppl 1):S15–S21

    PubMed  Google Scholar 

  • Pacheco I, Michiro O, Jin M, Sasahara H, Iwabuchi A, Odashima M, Konishi N, Wada I, Masamune O, Watanabe S (2000) Corticosteroid pretreatment prevents small intestinal lesions induced by acetic acid-perfusion model in rats. Dig Dis Sci 45:2337–2346

    Article  PubMed  Google Scholar 

  • Peskar BM, Maricic N (1998) Role of prostaglandins in gastroprotection. Dig Dis Sci 43(Suppl 9):23S–29S

    PubMed  Google Scholar 

  • Richardson P, Hawkey CJ, Stack WA (1998) Proton pump inhibitors. Pharmacology and rationale for use in gastrointestinal disorders. Drugs 56:307–335

    PubMed  Google Scholar 

  • Savoye G, Miralles-Barrachina O, Dechelotte P, Belmonte-Zalar L, Brung-Lefebvre M, Zalar A, Hochain P, Herve S, Colin R, Lerebours E, Ducrotte P (2001) Low levels of gastric mucosal glutathione during upper gastric bleeding associated with the use of nonsteroidal anti-inflammatory drugs. Eur J Gastroenterol Hepatol 13:1309–1313

    Article  PubMed  Google Scholar 

  • Scarpignato C, Pelosini I (1999) Prevention and treatment of non-steroidal anti-inflammatory drug-induced gastro-duodenal damage: rationale for the use of antisecretory compounds. Ital J Gastroenterol Hepatol 31(Suppl 1):S63–S72

    PubMed  Google Scholar 

  • Simmons DL, Botting RM, Hla T (2004) Cyclooxygenase isoenzymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev 56:387–437

    Article  PubMed  Google Scholar 

  • Somasundram S, Sigthorsson G, Simpson RJ, Watts J, Jacob M, Tavares IA, Rafi S, Roseth A, Foster R, Price AB, Wrigglesworth JM, Bjarnason I (2000) Uncoupling of intestinal mitochondrial oxidating phosphorylation and inhibition of cyclooxygenase are required for the development of NSAID-enteropathy in the rat. Aliment Pharmacol Ther 14:639–650

    Article  PubMed  Google Scholar 

  • Stupnicki T, Dietrich K, Gonzales-Carro P, Straszak A, Terjung A, Thomas KB, Luhmann R, Fischer R (2003) Efficacy and tolerability of pantoprazole compared with misoprostol for the prevention of NSAID-related gastrointestinal lesions and symptoms in rheumatic patients. Digestion 68:198–208

    Article  PubMed  Google Scholar 

  • Suzuki M, Nakamura M, Mori M, Miura S, Tsuchiya M, Ishii H (1995) Lansoprazole inhibits oxygen-derived free radical production from neutrophils activated by Helicobacter pylori. J Clin Gastroenterol 20(Suppl 2):S93–S96

    PubMed  Google Scholar 

  • Suzuki M, Mori M, Miura S, Suematsu M, Fukumura D, Kimura H, Ishii H (1996) Omeprazole attenuates oxygen-derived free radical production from human neutrophils. Free Radic Biol Med 21:727–731

    Article  PubMed  Google Scholar 

  • Szabo S (1991) Mechanisms of gastric mucosal injury and protection. J Clin Gastroenterol 13(Suppl 2):S21–S34

    PubMed  Google Scholar 

  • Takeuchi K, Mizoguchi H, Araki H, Komoike Y, Suzuki K (2001) Lack of gastric toxicity of nitric oxide-releasing indomethacin, NCX-530, in experimental animals. Dig Dis Sci 46:1805–1818

    Article  PubMed  Google Scholar 

  • Tanaka A, Hase S, Miyazawa T, Takeuchi K (2002) Up-regulation of cyclooxygenase-2 by inhibition of cyclooxygenase-1: a key to nonsteroidal anti-inflammatory drug-induced intestinal damage. J Pharmacol Exp Ther 300:754–761

    Article  PubMed  Google Scholar 

  • Tashima K, Fujita A, Takeuchi K (2000) Aggravation of ischemia/reperfusion-induced gastric lesions in streptozotocin-diabetic rats. Life Sci 67:1707–1718

    Article  PubMed  Google Scholar 

  • Tsuji S, Sun W-H, Tsuji M, Kawai N, Kimura A, Kakiuchi Y, Yasumaru S, Komori M, Murata H, Sasaki Y, Kawano S, Hori M (2002) Lansoprazole induces mucosal protection through gastrin receptor-dependent up-regulation of cyclooxygenase-2 in rats. J Pharmacol Exp Ther 303:1301–1308

    Article  PubMed  Google Scholar 

  • Vane JR, Botting RM (1998) Anti-inflammatory drugs and their mechanism of action. Inflamm Res 47(Suppl 2):S78–S87

    Article  PubMed  Google Scholar 

  • Wallace JL (2001) Pathogenesis of NSAID-induced gastroduodenal mucosal injury. Best Pract Res Clin Gastroenterol 15:691–703

    Article  PubMed  Google Scholar 

  • Wallace JL, Granger DN (1996) The cellular and molecular basis of gastric mucosal defence. FASEB J 10:731–740

    PubMed  Google Scholar 

  • Wallace JL, Reuter B, Cicala C, McKnight W, Grisham M, Cirino G (1994) A diclofenac derivative without ulcerogenic properties. Eur J Pharmacol 257:249–255

    Article  PubMed  Google Scholar 

  • Wandall JH (1992) Effects of omeprazole on neutrophil chemotaxis, super oxide production, degranulation, and translocation of cytochrome b245. Gut 33:617–621

    PubMed  Google Scholar 

  • Whittle BJR (2003) Gastrointestinal effects of nonsteroidal anti-inflammatory drugs. Fundam Clin Pharmacol 17:301–313

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The present work was supported by a Research Grant by Recordati Industria Chimica e Farmaceutica S.p.A., Milan, Italy.

Author information

Authors and Affiliations

  1. Interdepartmental Centre for Research in Clinical Pharmacology and Experimental Therapeutics, University of Pisa, Via Roma 55, 56126, Pisa, Italy

    M. Fornai, R. Colucci, M. Tuccori, L. Antonioli, V. Lubrano, C. Blandizzi & M. Del Tacca

  2. Department of Human Morphology and Applied Biology, University of Pisa, Via Roma 55, 56126, Pisa, Italy

    G. Natale & A. Abramo

  3. Recordati Industria Chimica e Farmaceutica, Via M. Civitali 1, 20148, Milan, Italy

    G. Carazzina

  4. Department of Internal Medicine, University of Pisa, Via Roma 67, 56126, Pisa, Italy

    S. Baldi

Authors
  1. M. Fornai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Natale
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Colucci
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Tuccori
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G. Carazzina
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. L. Antonioli
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. S. Baldi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. V. Lubrano
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. A. Abramo
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. C. Blandizzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. M. Del Tacca
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Del Tacca.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fornai, M., Natale, G., Colucci, R. et al. Mechanisms of protection by pantoprazole against NSAID-induced gastric mucosal damage. Naunyn Schmied Arch Pharmacol 372, 79–87 (2005). https://doi.org/10.1007/s00210-005-1075-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00210-005-1075-1

Keywords

Search

Navigation